NCT03707977View on ClinicalTrials.gov

Dual bNAb Treatment in Children

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 17, 2019

Primary Completion Date

December 3, 2021

Study Completion Date

December 3, 2021

Conditions
HIV Infection
Interventions
DRUG

ART

ART will not be provided by the study. Participants will continue to receive their ART regimen they were receiving prior to enrolling in the study.

BIOLOGICAL

VRC01LS

Administered by intravenous (IV) infusion

BIOLOGICAL

10-1074

Administered by intravenous (IV) infusion

Trial Locations (2)

Unknown

Francistown Non-Network CRS, Francistown

Botswana Harvard AIDS Institute Partnership CRS Non-Network, Gaborone

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT03707977 - Dual bNAb Treatment in Children | Biotech Hunter | Biotech Hunter